GGrantIndex
← Leaderboards

Kenneth M Kozloff

University Of Michigan At Ann Arbor

$4,214,322
Attributed
$4,214,322
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $994K · FY201125
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,214,322 · 7

By mechanism

R01$2,426,367 · 2
R21$785,827 · 2
P01$609,228 · 2
S10$392,900 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Bone

Research focus

BoneOsteoclastsTissuesSkeletonFutureImageBone MassOsteogenesisBaseCollagen Type IPreventBiomechanicsOsteoblastsCharacteristicsCellsMouse ModelChildhoodClinical TreatmentMutationDefectBisphosphonateBone CellLaboratoriesAntibody Therapy

Grant awards (15)

Determining mechanisms of bone remodeling response to high metabolic demands of aerobic exercise$658,940
R01 · FY2025 · AR · contact PI
Core C - Bone Core$225,690
P01 · FY2021 · CA · contact PI
Core C - Bone Core$219,974
P01 · FY2020 · CA · contact PI
Biologic signatures for sclerostin antibody responsiveness in human and murine models of osteogenesis imperfecta$205,920
R21 · FY2020 · AR · contact PI
Biologic signatures for sclerostin antibody responsiveness in human and murine models of osteogenesis imperfecta$171,600
R21 · FY2019 · AR · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$336,856
R01 · FY2016 · AR · contact PI
In Vivo Micro-Computed Tomography Imaging System$392,900
S10 · FY2015 · OD · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$337,593
R01 · FY2015 · AR · contact PI
Bone Core$163,564
P01 · FY2015 · CA · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$99,896
R01 · FY2015 · AR · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$331,522
R01 · FY2014 · AR · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$321,997
R01 · FY2013 · AR · contact PI
Sclerostin Antibody Therapy for Treatment of Osteogenesis Imperfecta$339,563
R01 · FY2012 · AR · contact PI
Bone Turnover Effects on Bisphosphonate Concentration in the Mandible$184,638
R21 · FY2012 · DE · contact PI
Bone Turnover Effects on Bisphosphonate Concentration in the Mandible$223,669
R21 · FY2011 · DE · contact PI